You may pick up on the theme of this Blog either in Ecclesiastes 3:1 or by listening to the music of Pete Seeger so Turn! Turn! Turn! over the holiday period. No matter your preference, I will be moving my offices to 618 West Fulton Street, Chicago, Illinois 60661 as of January 1st, 2023.
The good news is that I am not too old to change and stay up to date; actually, to stay at the forefront of Evidence-Based, Regenerative Medicine. The new setting will allow me to better control the escalating cost of Cellular Orthopedics. Equally important, I will be better able to introduce advancing technology and update our outcomes documentation methodology. Of course, our team with whom I have worked over the past many years will remain intact.
Patients will soon receive an announcement in the mail as to the change. Since our team is still working out the details, until further notice, our phone number will not change. I will post updates in the next several blogs regarding details such as parking, etc. Our treatment options will also increase as we are adding a new form for micronized adipose tissue to treatment options starting in mid-January. Additionally, aware that some patients are traveling out of the country for Stem Cell treatments, I will also be able to provide those opportunities in my new Chicago office; so, you will no longer need to travel offshore for the advanced treatment of an arthritic joint. At the same time, our updated biologic interventions will now offer increases in platelet-derived growth factors, A2M, cytokines, fibrinogen, IRAP, and VEGF.
While all this is taking place, we are exploring the location of a north suburban satellite office. When that location has been finalized, the announcement will be posted on the Blog or you will learn more when you schedule an appointment. At the time of your initial appointment in the Fulton Street setting, you will note that the proximity to the office space marked Chicago Arthritis on the Northeast corner of Fulton and Des Plains Streets. The proximity to a Rheumatologist will allow for a more comprehensive overview of each patient prior to and following a Regenerative Cellular and Biologic intervention. It is important to differentiate for instance between inflammatory arthritis and Osteoarthritis before providing informed consent for evidence-based joint intervention. Medical management of arthritis with prescription anti-inflammatories has a place, as does physical therapy, in helping a patient deal with impairments affecting many joints.
Until December 31, 2022, I will remain in my existing offices. To schedule an appointment, continue to call (312) 475-1893. You may visit my website at www.sheinkopmd.com.
Tono-Bungay by H.G. Wells, tells the story of a miraculous cure-all, Tono-Bungay, that is in fact nothing other than a pleasant-tasting liquid with no positive effects. Nonetheless, when the young George Ponderevo is employed by his uncle Edward to help market this ineffective medicine, he finds his life overwhelmed by its sudden success. Soon, the worthless substance is turned into a formidable fortune.
H.G. Wells first published the book in 1909, but he may well have been describing the relatively unregulated market place for the charlatans and camp followers promoting Regenerative Medicine and Stem Cells in 2020. As an orthopedic surgeon with an ethos of helping arthritic patients postpone, perhaps avoid a major joint replacement, I am happy to share the October 14, 2020, press release post: “The American Academy of Orthopaedic Surgeons (AAOS) continues to demonstrate its commitment to advancing the quality of musculoskeletal care in a fully transparent and scientific way. Debuting today as a new member benefit, the AAOS Biologics Dashboard is a dynamic online tool designed to help orthopaedic surgeons navigate the FDA approval status of biologic-based interventions. The development of the AAOS Biologics Dashboard is just one of several efforts within the Academy’s Biologics Initiative that offers evidence-based guidance to the musculoskeletal health community.”
Orthobiologics for the Musculoskeletal System
Orthobiologics is an evolving frontier. As new therapies, such as regenerative medicine therapies and stem-cell injections, become increasingly popular due to their potential to regenerate tissue and enhance bone healing and reduce pain, the AAOS continues to recognize a need for reliable and credible sources, of evidence-based therapies. These new tools further validate my ongoing commitment in separating science from anecdote with the goal of helping my patients receive the highest quality of evidence-based care.
What was to have initially taken place this month, basically a purge of the products not FDA approved in the marketplace, has been delayed until May of 2021. In my practice, I can assure my patient that all care will anticipate the FDA rules and be compliant with the FDA regulatory apparatus by prior screening on the new AAOS Biologics Dashboard. Although there is no board certification for a regenerative medicine or stem cell physician, look for the letters FAAOS after the M.D., as they describe membership in the American Academy of Orthopedic Surgeons and is your protection and quality assurance if you chose to undergo a stem cell or cellular orthopedic procedure.
To schedule a consultation, call (312) 475-1893. My web site is accessed via www.sheinkopmd.com
Tags: cellular therapy, musculoskeletal system, stem cell therapy, treating muscle pain